Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?

Background Patent ductus arteriosus (PDA) is one of the most prevalent problems in preterm infants. Although ibuprofen represents one of the choices for the closure of PDA, this treatment can cause severe gastrointestinal and adverse renal effects and worsen platelet function. Effective therapy for...

Full description

Bibliographic Details
Main Author: Reham S Abd Al Hamid
Format: Article
Language:English
Published: General Organization of Teaching Hospitals and Institutes 2020-01-01
Series:Journal of Medicine in Scientific Research
Subjects:
Online Access:http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2020;volume=3;issue=2;spage=108;epage=111;aulast=Abd
_version_ 1797226411525668864
author Reham S Abd Al Hamid
author_facet Reham S Abd Al Hamid
author_sort Reham S Abd Al Hamid
collection DOAJ
description Background Patent ductus arteriosus (PDA) is one of the most prevalent problems in preterm infants. Although ibuprofen represents one of the choices for the closure of PDA, this treatment can cause severe gastrointestinal and adverse renal effects and worsen platelet function. Effective therapy for PDA had been suggested as paracetamol. Aim Our study is aiming to compare the efficacy and safety of paracetamol and ibuprofen. Patients and methods A prospective observational, single-center study was performed from December 2016 until August 2017, at ElGalaa Teaching Hospital in Cairo. In this study we included neonates with a gestational age of 28–36 weeks, diagnosed with a significant hemodynamically PDA using clinical and ultrasonographic cardiac evaluation. The pediatric cardiologist performed an echocardiographic examination before the start of the treatment and after seven days. Results We found that paracetamol had good efficacy on PDA in preterm infants, and the closure rate of paracetamol was comparable to that of ibuprofen. Conclusion Paracetamol may confer comparable treatment efficacy for the closure of PDA to ibuprofen, although paracetamol is associated with lower risk of adverse events.
first_indexed 2024-04-24T14:24:29Z
format Article
id doaj.art-3f74c80407684b639e0164952558a3d2
institution Directory Open Access Journal
issn 2537-091X
2537-0928
language English
last_indexed 2024-04-24T14:24:29Z
publishDate 2020-01-01
publisher General Organization of Teaching Hospitals and Institutes
record_format Article
series Journal of Medicine in Scientific Research
spelling doaj.art-3f74c80407684b639e0164952558a3d22024-04-03T05:22:05ZengGeneral Organization of Teaching Hospitals and InstitutesJournal of Medicine in Scientific Research2537-091X2537-09282020-01-013210811110.4103/JMISR.JMISR_56_18Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?Reham S Abd Al HamidBackground Patent ductus arteriosus (PDA) is one of the most prevalent problems in preterm infants. Although ibuprofen represents one of the choices for the closure of PDA, this treatment can cause severe gastrointestinal and adverse renal effects and worsen platelet function. Effective therapy for PDA had been suggested as paracetamol. Aim Our study is aiming to compare the efficacy and safety of paracetamol and ibuprofen. Patients and methods A prospective observational, single-center study was performed from December 2016 until August 2017, at ElGalaa Teaching Hospital in Cairo. In this study we included neonates with a gestational age of 28–36 weeks, diagnosed with a significant hemodynamically PDA using clinical and ultrasonographic cardiac evaluation. The pediatric cardiologist performed an echocardiographic examination before the start of the treatment and after seven days. Results We found that paracetamol had good efficacy on PDA in preterm infants, and the closure rate of paracetamol was comparable to that of ibuprofen. Conclusion Paracetamol may confer comparable treatment efficacy for the closure of PDA to ibuprofen, although paracetamol is associated with lower risk of adverse events.http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2020;volume=3;issue=2;spage=108;epage=111;aulast=Abdechocardiographyibuprofenparacetamolpatent ductus arteriosus
spellingShingle Reham S Abd Al Hamid
Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
Journal of Medicine in Scientific Research
echocardiography
ibuprofen
paracetamol
patent ductus arteriosus
title Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
title_full Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
title_fullStr Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
title_full_unstemmed Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
title_short Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
title_sort patent ductus arteriosus treatment in preterm neonates which is the drug of choice paracetamol vs ibuprofen
topic echocardiography
ibuprofen
paracetamol
patent ductus arteriosus
url http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2020;volume=3;issue=2;spage=108;epage=111;aulast=Abd
work_keys_str_mv AT rehamsabdalhamid patentductusarteriosustreatmentinpretermneonateswhichisthedrugofchoiceparacetamolvsibuprofen